Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8+ T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 87-95

  Maeurer, Markus J ^a,b,c   Martin, Dina ^a   Elder, Elaine ^b   Storkus, Walter J ^a,b   Lotze, Michael T ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A1 ANTIGEN; INTERLEUKIN 2;

ANTIGEN RECOGNITION; ARTICLE; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-A1 ANTIGEN; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 0030053491     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Lotze, M. T., Chang, A. E., Seipp, C. A., Simpson, C., Vett, J. T. and Rosenberg, S. A. High dose recombinant interleukin-2 in the treatment of patients with disseminated cancer: responses, treatment related morbidity and histologic findings. J. Am. Med. Assoc., 256: 3117-3124, 1986.
2. Rosenberg, S. A., Packard, B., Aebersold, P. M., Solomon, D., Topalian, S., L, Toy, A , Simon, P., Lotze, M. T., Yang, J. C., Seipp, C. A., Simpson, C., Carter, C., Bock, S., Schwartzentruber, D., Wei, J. P., and White, D. E. Immunotherapy of patients with metastatic melanoma using tumor infiltrating lymphocytes and interleukin-2. N. Engl. J. Med., 319: 1676-1680, 1988.
3. Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. M., Mule, J. J., Rosenberg, S. A., and Bennick, J. R. Identification of human cancers deficient in antigen processing. J. Exp. Med., 177: 265-272, 1993.
4. De Plaen, E., Lurquin, C., Van Pel, A., Mariame, B., Szikora, J., Wolfel, T., Sibille, C., Chomez, P., and Boon, T. Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P19A and identification of the turn-mutation. Proc. Natl. Acad. Sci. USA, 85: 2274-2278, 1988.
5. Van den Eynde, B., Lethe, B., Van Pel, A., De Plaen, E., and Boon, T. The gene coding for a major tumor rejection antigen to tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med., 173: 1373-1380, 1991.
6. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res., 53: 5613-5616, 1993.
7. Nakagomi, H., Petersson, M., Magnusson, I., Jublin, C., Matsuda, M., Mellstedt, H., Taupin, J., Vivier, E., Anderson, P., and Kiessling, R. Decreased expression of the signal-transducing ζ chain in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res., 53: 5610-5612., 1993.
8. + tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Eur. J. Immunol., 24: 1966-1973, 1994.
9. Storkus, W. J., Zeh, H. J., II, Maeurer, M. J., Salter, R. D., and Lotze, M. T. Identification of human melanoma peptides recognized by class I-restricted tumor infiltrating lymphocytes. J. Immunol., 151: 3719-3727, 1993.
10. Slingluff, C. L., Jr., Cox, A L., Henderson, R. A., Hunt, D. F., and Engelhard, V. H. Recognition of human melanoma cells by HLA-A2.1-restricted cyototoxic T lymphocytes is mediated by at least six shared peptide epitopes J Immunol., 150: 2955-2963, 1993.
11. Brichard, V , Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178, 489-495, 1993.
12. Wolfel, T, Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Buschenfelde, K.-H, and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol., 24: 759-764, 1994.
13. Kawakami, Y., Eliyahu, S., Delgado, C. H,. Robbins, P. F., Sakaguchi, K., Appella, E., Yanelli, J. R., Adema, G. J., Kimi, T., and Rosenberg, S. A. Identification of melanoma antigens recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection Proc. Natl. Acad. Sci. USA, 91: 6458-6462, 1994.
14. Bakker, A. B. H., Schreurs, M. W. J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp100 is recognized by melanoma derived tumor infiltrating lymphocytes. J. Exp. Med , 179: 1005-1009, 1994.
15. Cox, A. L,. Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard V. H., Hunt, D. F., and Slingluff, C L. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines Science (Washington DC), 264: 716-719, 1994.
16. Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yanelli, J. R., Appella, E., and Rosenberg, S. A. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol , 154: 2257-2265, 1995.
17. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
18. Coulie, P. G., Brichard, V., Van Pel, A., Wolfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J-P., Renauld, J-C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med , 180: 35-42, 1994.
19. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yanelli, J. R., Apella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
20. + cytotoxic T lymphocytes. J. Exp. Med., 181: 363-368, 1995.
21. Van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boel, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
22. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaeri, E., Van Den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
23. Traversari, C., Van der Bruggen, P., Luescher, I. F, Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., and Amar-Costesec, A. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by CTL directed against tumor antigen MZ2-E. J. Exp. Med., 776: 1453-1459, 1992.
24. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
25. Salgaller, M. L , Weber, J S., Koenig, S., Yanelli, J. R., and Rosenberg, S. A. Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol. Immunother., 39: 105-116, 1994.
26. Zakut, R., Topalian, S. L , Kawakami, Y., Mancini, M., Eliyahu, S., and Rosenberg, S. A. Differential expression of MAGE-1, -2, -3 messenger RNA in transformed and normal cell lines. Cancer Res., 53: 54-57, 1993.
27. Zeh, H J., III, Leder, G. H., Lotze, M. T., Salter, R. D., Tector, M., Stuber, G., Modrow, S., and Storkus, W. J. Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Hum. Immunol., 39: 79-86, 1994
28. Elder, E. M., and Whiteside, T L. Processing of tumors for vaccine and/or tumor infiltrating lymphocytes. In: N. R. Rose, E. Conway de Macaio, J. L. Fahey, H. Friedman, and G. M. Penn (eds.), Manual of Clinical Laboratory Immunology, Ed. 4, pp. 817-819. Washington, DC: American Society for Microbiology, 1992.
29. Storkus, W. J., Zeh, H. J., III, Salter, R. .D, and Lotze, M. T. Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells. J. Immunother., 14: 94-103, 1993.
30. Tanabe, M., Sekimata, M., Ferrone, S., and M. Takiguchi, Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J. Immunol., 148: 3202-3209, 1992.
31. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
32. + T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int. J. Cancer, 58: 69-79, 1994.
33. Schwartzentruber, D. J., Stetler-Stevenson, M., Rosenberg, S. A., and Topalian, S. L. Tumor-infiltrating lymphocytes derived from selective B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulation. Blood. 82: 1204-1211, 1993.
34. Schwartzentruber, D. J., Solomon, D., Rosenberg, S. A., and Topalian, S. L. Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. Blood, 12: 1-12, 1992.
35. Robbins, P., El-Gamil, M., Kawakami, Y., and Rosenberg, S. A. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54: 3124-3126, 1994.
36. + T cells specifically recognize a shared melanoma associated antigen encoded by the tyrosinase gene. Proc Natl. Acad. Sci. USA, 91: 9461-9465, 1994.
37. Wang, R-F., Robbins, P. F, Kawakami, Y., Kang, X-Q, and Rosenberg, S. A. Identification of a gene encoding a melanoma rumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med., 181: 799-804, 1995.
38. Van der Bruggen, P., Szikora, J-P., Boel, P. L., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melnomas expressing HLA-Cw*16018. Eur. J. Immunol., 24: 2134-2140, 1994.
39. Anichini, A., Squarcina, P., and Parmian, G. Determination of frequency of HLA-A2-restricted cytotoxic T lymphocyte precursors directed to melanoma and normal melanocytes: evidence for two classes of antigens on human melanoma (Abstract). Proc. Am. Assoc. Cancer Res., 35: 494, 1994.
40. Brichard, V., Van der Bruggen, P., Van Pel, A., De Plaen, E., Coulie, P., and Boon, T. Tumor antigens recognized by cytotoxic lymphocytes: hope for specific immunotherapy (Abstract). Gene Ther., (Suppl 2): A10, 1994.
41. Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka, G., and Grey, H. M. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu Rev. Immunol., 12: 413-431, 1994.
42. Jameson, S. C., and Bevan, M. J. T cell receptor antagonists and partial agonists. Immunity, 2: 1-11, 1995.
43. Evavold, B. D., and Allen, P. M Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (Washington DC), 252: 1308-1310, 1991.
44. Klenerman, P., Rowland-Jones, S., McAdam, S., Edwards, J., Daenke, S., Lalloo, D., Koeppe, B., Rosenberg, W , Boyd, D., Edwards, A., Giangrande, P., Phillips, R. E., and McMichael, A. J. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Science (Washington DC). 369: 403-407, 1994.
45. Bertoletti, A., Sette, A., Chisari, F. V., Penna, A., Levrero, M., De Carli, M., Foaccadori, F., and Ferrari, C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature (Lond.), 369: 407-410, 1994